Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 75951 - 75975 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Sorafenib	Approved Investigational	PLK3	1263	upregulated	sorafenib results in increased expression of PLK3 mRNA	1p34.1	A21790
Sorafenib	Approved Investigational	PRKCA	5578	downregulated	sorafenib results in decreased expression of PRKCA mRNA	17q24.2	A21790
Sorafenib	Approved Investigational	STC1	6781	downregulated	sorafenib results in decreased expression of STC1 mRNA	8p21.2	A24331
Sorafenib	Approved Investigational	TNFRSF10B	8795	upregulated	sorafenib results in increased expression of TNFRSF10B mRNA	8p21.3	A24326
Sorafenib	Approved Investigational	TXNRD1	7296	upregulated	sorafenib results in increased expression of TXNRD1 mRNA	12q23.3	A21790
Sotalol	Approved Investigational	ASAH1	427	upregulated	Sotalol results in increased expression of ASAH1 mRNA	8p22	A20430
Sotalol	Approved Investigational	ASNS	440	downregulated	Sotalol results in decreased expression of ASNS mRNA	7q21.3	A20438
Sotalol	Approved Investigational	ASNS	440	upregulated	Sotalol results in increased expression of ASNS mRNA	7q21.3	A20430
Sotalol	Approved Investigational	FNDC4	64838	upregulated	Sotalol results in increased expression of FNDC4 mRNA	2p23.3	A20430
Sotalol	Approved Investigational	GDPD3	79153	downregulated	Sotalol results in decreased expression of GDPD3 mRNA	16p11.2	A20430
Sotalol	Approved Investigational	GDPD3	79153	upregulated	Sotalol results in increased expression of GDPD3 mRNA	16p11.2	A20430
Sotalol	Approved Investigational	INHBE	83729	downregulated	Sotalol results in decreased expression of INHBE mRNA	12q13.3	A20430
Sotalol	Approved Investigational	INHBE	83729	upregulated	Sotalol results in increased expression of INHBE mRNA	12q13.3	A20430
Sotalol	Approved Investigational	LSS	4047	downregulated	Sotalol results in decreased expression of LSS mRNA	21q22.3	A20438
Sotalol	Approved Investigational	NR0B2	8431	downregulated	Sotalol results in decreased expression of NR0B2 mRNA	1p36.11	A20438 A20430
Sotalol	Approved Investigational	NR0B2	8431	upregulated	Sotalol results in increased expression of NR0B2 mRNA	1p36.11	A20430
Sotalol	Approved Investigational	NUPR1	26471	upregulated	Sotalol results in increased expression of NUPR1 mRNA	16p11.2	A20430
Sotalol	Approved Investigational	PHYH	5264	upregulated	Sotalol results in increased expression of PHYH mRNA	10p13	A20646
Sotalol	Approved Investigational	SERPINA3	12	upregulated	Sotalol results in increased expression of SERPINA3 mRNA	14q32.13	A20430
Sotalol	Approved Investigational	SLC2A3	6515	upregulated	Sotalol results in increased expression of SLC2A3 mRNA	12p13.31	A20438
Sotalol	Approved Investigational	WIPI1	55062	upregulated	Sotalol results in increased expression of WIPI1 mRNA	17q24.2	A20430
Sphingosine	Investigational	CYP17A1	1586	upregulated	Sphingosine results in increased expression of CYP17A1 mRNA	10q24.32	A24332
Spironolactone	Approved Investigational	ABCB1	5243	upregulated	Spironolactone results in increased expression of ABCB1 mRNA	7q21.12	A24333
Spironolactone	Approved Investigational	CYP3A4	1576	upregulated	Spironolactone results in increased expression of CYP3A4 mRNA	7q22.1	A21238
Stannous chloride	Approved	ESR1	2099	downregulated	stannous chloride results in decreased expression of ESR1 mRNA	6q25.1-q25.2	A21248

Displaying entries 75951 - 75975 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability